Nearly two months after Pfizer’s COVID-19 antiviral pill Paxlovid was authorized by the FDA, the drugmaker released final efficacy and safety data for the pill in a study published Feb. 16 in the New England Journal of Medicine.
Category: White Papers
The pros and cons of patient surveys, per 3 physicians
Some physicians take issue with patient surveys because they’re often outdated and may not always be a true representation of physicians’ practice behavior, Medscape reported Jan. 19.
3 states with very high flu activity; another pediatric death — 7 CDC notes
Three states reported very high flu activity for the week ending Jan. 8, according to the agency’s most recent FluView report.
Omicron may be more mild, but not for hospitals — here’s why
As cases and hospitalizations rapidly rise nationwide, healthcare workers across 11 states told The Atlantic how and why this surge is pushing their hospitals to the brink.
FDA allows abortion pill to be sent by mail
Read the full post on Becker's Hospital Review – Healthcare News
Michigan governor proposes $220M Lansing public health lab replacement
Read the full post on Becker's Hospital Review – Healthcare News
Montana National Guard to help state’s lab with COVID-19 response
Read the full post on Becker's Hospital Review – Healthcare News
Lab tech company unveils testing system that could set a new benchmark
Read the full post on Becker's Hospital Review – Healthcare News
Global market for lab freezers projected to climb 21% by 2026
Read the full post on Becker's Hospital Review – Healthcare News
7 things to know about MIS-C, the severe pediatric COVID-19 complication
Read the full post on Becker's Hospital Review – Healthcare News
